Skip to Main Content

Paper Details

Why participation in an international clinical trial platform matters during a pandemic? Launching REMAP-CAP in Japan.
J Intensive Care
2
2021
Author NameAffiliation
Ayumi ShintaniGraduate School of Medicine, Osaka City University
  • 1 - 1

Datasets

Release 1.2